PCSK9, the short track road from discovery as drug target towards the clinic - PACE-CME

PCSK the short track road from discovery as drug target towards the clinic

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Epigenetics: A closer look at BET inhibition
Epigenetics: A closer look at BET inhibition
ESC 2016
Epigenetics: A closer look at BET inhibition
No indication for difference in efficacy between potent platelet inhibitors after PCI
No indication for difference in efficacy between potent platelet inhibitors after PCI
ESC 2016
No indication for difference in efficacy between potent platelet inhibitors after PCI
- Steen Dalby Kristensen, MD
Heart failure news at the ESC
Heart failure news at the ESC
ESC 2016
Heart failure news at the ESC
- Frank Ruschitzka, MD
Targeting residual inflammatory risk as a strategy to lower CV risk
Targeting residual inflammatory risk as a strategy to lower CV risk
CSI 2016 ESC
Targeting residual inflammatory risk as a strategy to lower CV risk
- prof. Paul Ridker, MD